Megan M Davis

4PUBLICATIONS
41CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 09, 2022
BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion.

In-Young Jung, Vivek Narayan, Sierra McDonald

|Mar 29, 2022
Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia.

Saar Gill, Vanessa Vides, Noelle V Frey

|Feb 08, 2020
CRISPR-engineered T cells in patients with refractory cancer.

Edward A Stadtmauer, Joseph A Fraietta, Megan M Davis

|Oct 03, 2019
T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma.

Alfred L Garfall, Ehren K Dancy, Adam D Cohen

Pageof 1